Gheri R G, Bianchi R, Mariani G, Toccafondi R, Cappelli G, Brat A, Borghi A, Giusti G, Forti G
J Clin Endocrinol Metab. 1984 Mar;58(3):563-9. doi: 10.1210/jcem-58-3-563.
A clinically euthyroid 30-yr-old man with high serum levels of both total (T4, 14.5 micrograms/dl; T3, 272 ng/dl) and free (FT4, 33 pg/ml; FT3, 9.7 pg/ml) thyroid hormones and inappropriately normal TSH levels, both basally and after TRH stimulation, is described. Peripheral indices of thyroid hormone action and the patient's clinical status were not modified by the prolonged administration of supraphysiological doses of both T4 (up to 900 micrograms/day) and T3 (up to 80 micrograms/day), which decreased but did not completely abolish the TSH response to TRH. However, the TSH response to TRH was normally blunted by dexamethasone administration, which also reduced serum T4 and T3 levels to normal. T3 binding to nuclei of mononuclear leukocytes and cultured skin fibroblasts was normal. The overall pattern demonstrates that the patient was affected by partial peripheral resistance to thyroid hormone action. Study of the patient's family revealed the same hormone pattern in the patient's father, suggesting an autosomal dominant mode of inheritance. An in vivo study performed after the iv injection of tracer doses of [125I]T4 and [131I]T3, demonstrated increased production rates (PR) of both T4 [PR, 113.0 micrograms/day X m2; normal subjects, 55.4 +/- 12.3 (mean +/- SD); n = 13] and T3 (PR, 41.1 micrograms/day X m2; normal subjects, 16.3 +/- 2.7). In vivo conversion of T4 to T3 was also evaluated in the patient; a nearly normal T4 to T3 conversion factor was found (0.3108 vs. 0.2576 +/- 0.0422 in normal subjects). In four hyperthyroid patients, the T4 to T3 conversion factors were similar (0.2932 +/- 0.0600), while the PRs of T4 and T3 were increased (PR of T4, 308.6 +/- 85.6; PR of T3, 110.3 +/- 35.0 micrograms/day X m2) compared to those in the normal subjects.
本文描述了一名30岁临床甲状腺功能正常的男性,其血清总甲状腺激素(T4,14.5微克/分升;T3,272纳克/分升)和游离甲状腺激素(FT4,33皮克/毫升;FT3,9.7皮克/毫升)水平均升高,且基础状态及促甲状腺激素释放激素(TRH)刺激后促甲状腺激素(TSH)水平均正常但不恰当。甲状腺激素作用的外周指标及患者的临床状态并未因超生理剂量的T4(高达900微克/天)和T3(高达80微克/天)的长期给药而改变,这虽降低了但未完全消除TSH对TRH的反应。然而,地塞米松给药可使TSH对TRH的反应正常减弱,同时也使血清T4和T3水平降至正常。T3与单核白细胞和培养的皮肤成纤维细胞核的结合正常。整体情况表明该患者存在部分外周甲状腺激素抵抗。对患者家族进行研究发现,患者父亲也有相同的激素模式,提示为常染色体显性遗传模式。静脉注射微量示踪剂剂量的[125I]T4和[131I]T3后进行的体内研究表明,T4 [生成率(PR),113.0微克/天×平方米;正常受试者,55.4±12.3(均值±标准差);n = 13]和T3(PR,41.1微克/天×平方米;正常受试者,16.3±2.7)的生成率均增加。还对该患者体内T4向T3的转化进行了评估;发现T4向T3的转化因子接近正常(0.3108,而正常受试者为0.2576±0.0422)。在4名甲状腺功能亢进患者中,T4向T3的转化因子相似(0.2932±0.0600),而T4和T3的PR均升高(T4的PR,308.6±85.6;T3的PR,110.3±35.0微克/天×平方米),与正常受试者相比。